Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - Cancer Treatment Reviews
PLOS ONE: HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
Raji-HER2 cells | ADCC target cells | InvivoGen
Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness | HTML
PLOS ONE: Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive Assay for Monitoring Breast Cancer Progression
Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice | Scientific Reports
Various epigenetic markers involved in HER2 positive breast cancer.... | Download Scientific Diagram
PLOS ONE: High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - eBioMedicine
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports
Clinical applications of mouse models for breast cancer engaging HER2/neu
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response | Nature Cancer
Addgene: pcDNA3-HER2-DMVF-181-N
Breast cancer: a new target? | Recherche animale
Mitochondrial MKP1 Is a Target for Therapy-Resistant HER2-Positive Breast Cancer Cells | Cancer Research
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence - Shi - 2019 - Cancer Medicine - Wiley Online Library